Search
CO-ZENOVAN 160 MG / 12.5 MG, Comprimé pelliculé
Details
| --- | Description |
|---|---|
| Pack | Boite de 30 |
| Strength (Dosage) | 160 MG | 12.5 MG |
| Laboratory | ZENITH PHARMA |
| Ingredients | Hydrochlorothiazide | Valsartan |
| Therapeutic class | Antagoniste des récepteurs de l'angiotensine II avec diurétique |
| ATC code | C09DA03 |
| PPH | $8.74 |
| PPV | $13.98 |
| Refundable | Yes |
| Refund base | $13.98 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | Traitement de l’hypertension artérielle essentielle chez l’adulte. L'association Valsartan-Hydrochlorothiazide à dose fixe est indiqué chez les patients dont la pression artérielle n’est pas suffisamment contrôlée par le valsartan ou l’hydrochlorothiazide en monothérapie. |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications with one or more of the ingredients above
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem